Payer Evidence & Pricing Manager📣 إعلان

About the Role

Novo Nordisk is seeking a Payer Evidence & Pricing Manager to join their team in Riyadh, Saudi Arabia. This full-time role involves leading the development and execution of pre-launch market access, evidence generation, and pricing strategies for new product launches across the Novo Nordisk portfolio. The manager will be central to launch readiness, translating complex healthcare landscapes into actionable strategies to secure sustainable patient access for life-changing treatments.

About the Department

As part of International Operations, the largest operational unit covering 194 countries, you will join the Market Access and Health Economics team in Saudi Arabia. This team is responsible for ensuring optimal access and reimbursement outcomes for new and existing Novo Nordisk products. The role reports directly to the Associate Director Market Access and Health Economics, working at the intersection of evidence, pricing, policy, and payer engagement to bring treatments to patients.

Key Responsibilities

• Lead evidence generation planning by identifying evidence gaps and designing Health Economics and Outcomes Research (HEOR) initiatives, including health economic models, to support payer decision-making.
• Develop and recommend launch pricing strategies based on market dynamics, competitor activity, reimbursement environments, affordability, and access barriers.
• Map and engage public and private payers, reimbursement bodies, and provider stakeholders to understand access requirements and translate insights into actionable launch strategies.
• Create evidence-based value propositions and materials that articulate the clinical, economic, and healthcare system value of new launches for internal and external stakeholders.
• Partner cross-functionally with Medical, Regulatory, Commercial, Finance, and Market Access teams to drive launch readiness through clear coordination, milestone tracking, and risk mitigation.
• Support the preparation of price business cases, reimbursement submissions, and related market access documentation aligned with Novo Nordisk business needs and local payer requirements.
• Monitor changes in healthcare policy, Health Technology Assessment (HTA) developments, and pricing regulations to proactively assess implications for launch planning and recommend strategic actions.

Educational Background

• A Bachelor's degree in Health Economics, Pharmacy, Life Sciences, Public Health, Business Administration, or a related discipline is required.
• An advanced degree (MSc, MBA, PharmD, or PhD) is preferred.

Experience and Skills

• Minimum of 5 years of experience in market access, pricing, reimbursement, HEOR, or evidence generation within the pharmaceutical, biotech, or healthcare sector.
• Demonstrated experience in supporting or leading pre-launch planning, pricing strategy, reimbursement readiness, or payer-facing evidence development for new products.
• Strong understanding of Saudi Arabia's healthcare system, HTA and reimbursement processes, and the use of clinical, economic, and real-world evidence in access decision-making.
• Excellent cross-functional collaboration skills with the ability to align diverse stakeholders around launch priorities and communicate value clearly using evidence-based arguments.
• Experience managing external agencies, vendors, or research partners is preferred.

Work Environment and Location

This is a full-time position based in Riyadh, Saudi Arabia, offering an opportunity to contribute to improving health outcomes at scale across the globe.